Original Publication Date: 1 July, 2015
Publication / Source: Biomarkers in Medicine
Authors: Shumei Kato & Filip Janku
Advances in next-generation sequencing have provided new insights and new therapeutic options for patients with cancer. However, assessment of genomic aberrations, which is required for precision medicine, has been challenging because of the difficulties in capturing intratumoral heterogeneity and in real-time assessment of tumors.